PitchSend

Investor Presentaiton

Revenue: Business Units (incl. Forex Impact) (Bn JPY) FY2022 Q1 Results FY2023 Q1 Results YOY Japan Business 109.0 119.0 +10.0 Daiichi Sankyo Healthcare 15.3 17.1 +1.9 Oncolgy Business 27.5 70.6 +43.1 Enhertu 26.7 69.4 +42.7 Turalio 0.8 1.2 +0.4 American Regent 47.0 50.7 +3.6 Injectafer 14.1 13.2 -0.9 Venofer 12.4 15.8 +3.4 GE injectables EU Specialty Business 17.6 18.3 +0.8 37.1 41.5 +4.4 Lixiana 28.6 32.3 +3.7 Nilemdo/Nustendi 1.3 3.0 +1.7 Olmesartan 5.4 4.7 -0.7 ASCA (Asia, South and Central America) Business 31.9 39.5 +7.6 Currency Rate Daiichi-Sankyo USD/JPY 129.57 137.37 +7.80 EUR/JPY 138.10 149.46 +11.36 8

View entire presentation